THE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. SEE SCHEDULE OTHE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY24, THE FOUNDATION AWARDED $21.8 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$75.8M
-3.5% YoY
Annual Giving
$21.2M
+11.5% YoY
Grant Count
15
-16.7% YoY
Avg Grant Size
$1.4M
+33.8% YoY
About Marc Lustgarten Pancreatic Cancer
Based on IRS filings
Marc Lustgarten Pancreatic Cancer is a nonprofit organization focused on Human Services, based in UNIONDALE, NY. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $75.8M in total assets. In 2024, it awarded 15 grants totaling $21.2M. Net investment income was $1.3M.
Focus Areas
Ready to take the next step with Marc Lustgarten Pancreatic Cancer?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $75,802,153 | $78,560,475 | $78,505,397 |
| Revenue | $22,749,028 | $18,297,575 | $30,446,505 |
| Expenses | $30,962,554 | $28,681,699 | $33,834,657 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $1,266,888 | $-926,435 | $10,583,001 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
77 grants across all recorded years
Open Grants
2 open opportunities from Marc Lustgarten Pancreatic Cancer
Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research named in Honor of John Robert Lewis
MARC LUSTGARTEN PANCREATIC CANCER
Amount
$300,000
Deadline
Rolling / Open
Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research named in Honor of Ruth Bader Ginsburg
MARC LUSTGARTEN PANCREATIC CANCER
Amount
$300,000
Deadline
Rolling / Open
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| ANDREW LUSTGARTEN | CHAIRMAN | 2 | — |
| CHARLES F DOLAN | CHAIRMAN EMERITUS (END 3/31/24) | 2 | — |
| ROBERT F VIZZA | CHAIRMAN EMERITUS | 2 | — |
| JENNIE FORTUNOFF | SECRETARY | 2 | — |
| PHILIP D'AMBROSIO | TREASURER | 2 | — |
| JAMES L DOLAN | VICE CHAIRMAN (END 3/31/24) | 2 | — |
| ADAM SILVER | VICE CHAIRMAN | 2 | — |
| SOMMER BAZURO PHD | DIRECTOR | 2 | — |
| JOHN H COBB | DIRECTOR | 2 | — |
| JESSICA LUSTGARTEN COURTEMANCHE | DIRECTOR | 2 | — |
| QUENTIN F DOLAN | TRUSTEE (END 3/31/24) | 2 | — |
| MARCIA LUSTGARTEN | DIRECTOR | 2 | — |
| SHEILA MAHONY | DIRECTOR | 2 | — |
| CHARLES R SCHUELER | DIRECTOR | 2 | — |
| WILLA SHALIT | DIRECTOR | 2 | — |
| SCOTT PENBERTHY | DIRECTOR | 2 | — |
| SELWYN VICKERS | DIRECTOR | 2 | — |
| AARON KANTOFF | DIRECTOR (AS OF 6/7/2024) | 2 | — |
| RICHARD R BARAKAT MD MBA | DIRECTOR (AS OF 6/7/2024) | 2 | — |
| LINDA TANTAWI | CEO | 40 | $465,053 |
| KERRI KAPLAN | PRESIDENT | 40 | $328,848 |
| FAISAL JAWAID | CFO | 40 | $258,102 |
| ANDREW RAKEMAN | VP RESEARCH | 40 | $250,561 |
| GLEN PECK | SVP TECHNOLOGY & BUSINESS INTELLIGENCE | 40 | $260,177 |
| JACLYN P LYMAN | HEAD CLINICAL RESEARCH & DEVELOPMENT | 40 | $175,556 |
| STEPHANIE DERGARABEDIAN | NATIONAL DIRECTOR OF DEVELOPMENT | 40 | $156,431 |
| SUSAN M JACOBSON | DIRECTOR EXTERNAL & COMMUNITY RELATIONS | 40 | $155,304 |
Subject Areas
Focus areas based on grantmaking activity
Data last updated April 2026. Sourced from IRS Form 990-PF filings.
What could you do with Marc Lustgarten Pancreatic Cancer on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities